Fri, Jul 12, 2013 -- 9:00 AM

Genetic Mutation Holds Promise for Cholesterol-Busting Drug

Download audio (MP3)

Getty Images
Getty Images

After two women with similar genetic mutations were found to have astoundingly low cholesterol, drug companies began racing to release a super-drug that mimics that cholesterol-destroying mutation. New York Times science writer Gina Kolata and the director of the National Heart, Lung, and Blood Institute, Dr. Gary Gibbons, discuss these findings, and whether a super-drug could make high cholesterol a thing of the past.

Host: Dave Iverson


  • Dr. Gary Gibbons, director of the National Heart, Lung, and Blood Institute at the National Institutes of Health
  • Gina Kolata, science reporter for the New York Times

Become a KQED sponsor

Audio Archive

Episodes by Date

Calendar is loading...

Be a Part of Forum

Follow us on Twitter

Twitter bird in blue

Stay updated on show topics, relevant articles, and easily submit your questions.